JournalsHub
.online
Find My Journal
PT

Piotr Tomczak

Poznan University of Medical Sciences PL

ORCID iD 0000-0002-8816-5525
193
Publications
24,987
Citations
42
H-Index
87
i10-Index
20.12
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

188 total

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

Alain Ravaud, Robert J. Motzer, Hardev Pandha, Daniel J. George, Allan J. Pantuck et al. - New England Journal of Medicine, 2016
Cited by 769 OpenAlex

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Brian I. Rini, Bernard Escudier, Piotr Tomczak, А. Д. Каприн, Cezary Szczylik et al. - The Lancet, 2011
Cited by 1,840 OpenAlex

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

David Miles, Arlene Chan, Luc Dirix, Javier Cortés, Xavier Pivot et al. - Journal of Clinical Oncology, 2010
Cited by 885 OpenAlex

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski et al. - Journal of Clinical Oncology, 2009
Cited by 2,187 OpenAlex

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma PDF

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski et al. - New England Journal of Medicine, 2007
Cited by 5,739 OpenAlex

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice Dutcher, Robert A. Figlin et al. - New England Journal of Medicine, 2007
Cited by 3,645 OpenAlex

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer PDF

E O’Brien, Nely Wigler, Moshe Inbar, R. Rosso, Eva‐Maria Grischke et al. - Annals of Oncology, 2004
Cited by 1,706 OpenAlex

Research Topics

Renal cell carcinoma treatment (91) Renal and related cancers (29) Cancer Immunotherapy and Biomarkers (26) Cancer Genomics and Diagnostics (26) Theoretical and Computational Physics (24)

Affiliations

Privolzhsky Research Medical University
RU 2013 - 2013
University of Southern California
US 2009 - 2009
Roche (Switzerland)
CH 2010 - 2010
Poznan University of Medical Sciences
PL 2026 - 2006
Hebron University
PS 2025 - 2025

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now